Windlas Biotech Profile

Windlas Biotech Limited, founded in 2001, operates globally and is committed to developing, manufacturing and marketing drugs of high therapeutic value for human consumption. Our company has three major verticals – Contract Manufacturing, Contract Development (for both Indian markets and exports) and branded generic formulation development.

Windlas Biotech operates two WHO-GMP approved plants in Dehradun, which cater to the contract manufacturing requirements of many domestic formulators including Mankind, Emcure Pharma, Zuventus, Biocon, Ranbaxy and other companies in this sector. We continue to partner with several domestic pharmaceutical companies, and facilitate product filings in the developing market (RoW) with the aim of catering to the local players.

Moreover, we have a significant presence in contract manufacturing in other parts of Asia and in Africa through our local partners in these countries.

Our corporate headquarters is in Gurgaon, NCR (India). A wholly owned subsidiary, Windlas Healthcare Private Limited (WHC) engages in manufacturing generic products for regulated markets like United States and Europe.

We have been active for many years in the contract manufacturing business, offering a wide range of services for pharmaceuticals production

  • Supply to ASEAN and emerging markets
  • DEA approved production, storage and shipment of scheduled drugs
  • Packaging and distribution services
  • More than 100 successful full-scale product transfers in the last five years
  • Full services solutions from registration to distribution
  • Unique combination of high standards and cost competitiveness
  • “Conversion only” or “full service” contracts including material and inventory management

The key to our success in contract manufacturing is our world-class production network. With our business process excellence and comprehensive range of technologies, we consistently deliver the most suitable products at the right place and within desired timelines.

Our services are flexible, efficient and quality focused; the manufacturing processes are robust, and our facilities state-of-the-art. The combination of these factors enables us to meet the needs of our customers comprehensively. All our sites are subject to regular inspections by authorities and clients. Additionally, we employ continuous internal audits and operate in total compliance with current good manufacturing practice (cGMP).

We provide robust supply chain and risk management strategies through the Windlas sourcing network. Along with our streamlined business process, we endeavor to maintain our commitment to society by adhering to the permissible environmental and safety standards.

Innovation is at the core of our spirit in Windlas; we offer clients customized, end-to-end supply chain solutions for formulations. We leverage strategic partnerships for drug product (DP) supply, development and commercial phases. Our undeterred focus on quality and compliance guarantees competitive, industry-certified products to our clients.

In today’s highly competitive and dynamic pharmaceuticals market, exceeding customer expectations by providing superior commercial supply solutions and necessary flexibility constitutes the base of our successful partnerships.